Harbin Gloria Pharmaceuticals Co (SZSE:002437) Ending Cash Position : ¥701 Mil (As of Mar. 2024)

View and export this data going back to 2010. Start your Free Trial

What is Harbin Gloria Pharmaceuticals Co Ending Cash Position?

Harbin Gloria Pharmaceuticals Co's Ending Cash Position for the quarter that ended in Mar. 2024 was ¥701 Mil.

Harbin Gloria Pharmaceuticals Co's quarterly Ending Cash Position declined from Sep. 2023 (¥937 Mil) to Dec. 2023 (¥711 Mil) and declined from Dec. 2023 (¥711 Mil) to Mar. 2024 (¥701 Mil).

Harbin Gloria Pharmaceuticals Co's annual Ending Cash Position declined from Dec. 2021 (¥1,394 Mil) to Dec. 2022 (¥1,231 Mil) and declined from Dec. 2022 (¥1,231 Mil) to Dec. 2023 (¥711 Mil).

Harbin Gloria Pharmaceuticals Co Ending Cash Position Historical Data

The historical data trend for Harbin Gloria Pharmaceuticals Co's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Harbin Gloria Pharmaceuticals Co Ending Cash Position Chart

Harbin Gloria Pharmaceuticals Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Ending Cash Position

Get a 7-Day Free Trial

1,317.39

678.05

1,393.51

1,230.62

711.00

Harbin Gloria Pharmaceuticals Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Ending Cash Position	Get a 7-Day Free Trial															1,237.44	975.63	936.54	711.00	700.61

Harbin Gloria Pharmaceuticals Co Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Harbin Gloria Pharmaceuticals Co's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	1230.622	+	-519.618
	=	711

Harbin Gloria Pharmaceuticals Co's Ending Cash Position for the quarter that ended in Mar. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	711.004	+	-10.397
	=	701

Harbin Gloria Pharmaceuticals Co Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Harbin Gloria Pharmaceuticals Co's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Harbin Gloria Pharmaceuticals Co (SZSE:002437) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Harbin Gloria Pharmaceuticals Co Ltd (SZSE:002437) » Definitions » Ending Cash Position

Traded in Other Exchanges

N/A

Address

Beijing Road No 29, Harbin Economic and Technological Development Zone, Harbin, CHN, 150025

Website

http://www.gloria.cc

Harbin Gloria Pharmaceuticals Co Ltd is a tech biopharmaceutical enterprise. It is engaged in the research, development, production, and sale of pharmaceutical products primarily in China. The company offers cardiovascular drugs; cardiac cerebrovascular medication; vitamins and minerals; urinary tract drugs; urinary system medication; anti-tumor medication; endocrine system drugs; anti-infective drugs; digestive system medication; respiratory medication; and other medications.

Harbin Gloria Pharmaceuticals Co (SZSE:002437) Headlines

No Headlines